Company
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
JUL 31, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
This is an FDA supplemental approval for labeling changes to argatroban; it documents a regulatory action but does not contain clinical trial data or efficacy evidence.
MAY 27, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
This is an FDA supplemental approval for labeling changes to methotrexate; it documents a regulatory action, not clinical evidence of efficacy or safety.